View PHARMExcel shortlisted to win Business of the Year Award

PHARMExcel shortlisted to win Business of the Year Award

PHARMExcel is proud to be shortlisted to win Business of the Year 2022 at the SME Hertfordshire Business Awards. The award recognises innovation, commercial boldness and outstanding management practices.

Read More

View PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters

PHARMExcel are pleased to announce their latest Lancet publication on Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters

Read More

View PHARMExcel are pleased to announce the publication of the persistence of immunogenicity after seven Covid -19 vaccines given as third boosters

PHARMExcel are pleased to announce the publication of the persistence of immunogenicity after seven Covid -19 vaccines given as third boosters

Read More

View PHARMExcel celebrates 13 successful years!

PHARMExcel celebrates 13 successful years!

This month PHARMExcel reaches yet another milestone as it celebrates 13 years of successful business.

Read More

View PHARMExcel are delighted to announce their future collaboration with DIOSynVax to support the delivery of their forthcoming clinical trial program.

PHARMExcel are delighted to announce their future collaboration with DIOSynVax to support the delivery of their forthcoming clinical trial program.

This programme, (supported by CEPI funding), will provide the infrastructure to help design and select the lead antigen through proof-of-concept preclinical studies, progressing to initial clinical development through Phase I/II studies. DIOSynVax aim to establish clinical proof of concept for a novel vaccine candidate with the potential to provide broad protection against Sarbecovirus, Merbecovirus, Embecovirus and Nobecovirus.

Read More

View Adopting a New Agile Approach to CRO Clinical Trial Management

Adopting a New Agile Approach to CRO Clinical Trial Management

Following its reputation of excellence in delivering investigator-led studies, PHARMExcel was selected to manage the Covid-19 vaccine booster study.

Read More

View New EU Clinical Trial Regulation

New EU Clinical Trial Regulation

The new EU clinical trial regulation (CTR) is set to revolutionise clinical trial processes across Europe impacting all European Member states and organisations wanting to run clinical trials across these regions. How can organisations prepare for the change and set themselves up successfully with a new CTR programme?

Read More

View Yvanne Enever, Founder/CEO reflects on 2021

Yvanne Enever, Founder/CEO reflects on 2021

We are pleased to say that 2021 has seen PHARMExcel busier than ever. From delivering the Worlds’ first Booster Vaccine clinical trial leading to the shaping of UK Government policy, to welcoming new, key staff appointments and undertaking several charity events for Macmillan Cancer Support, Team PHARMExcel showed dedication to the cause. As we complete…

Read More

View PHARMExcel delighted to be the selected U.K. CRO delivering this pivotal clinical trial alongside colleagues at University Southampton, Cambridge and DIOSynVax.

PHARMExcel delighted to be the selected U.K. CRO delivering this pivotal clinical trial alongside colleagues at University Southampton, Cambridge and DIOSynVax.

Read More